Injection Lipolysis Market Size & Share, by Procedure (Surgical, Abdominoplasty, Liposuction, Non-surgical); Drug Type; Treatment Site; Service Provider - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Injection Lipolysis Industry - Regional Synopsis

North America Market Analysis

North America is anticipated to hold the highest share of 43.8% in the injection lipolysis market by the end of 2037. The availability of innovation in medical facilities, an increase in the level of disposable income, and nationwide implementation of cosmetic procedures are certain factors that are responsible for boosting the market growth in the region. In addition, the presence of organizations and their effective contributions through the adoption of cutting-edge technologies is yet another factor for the market to increasingly gain more exposure in the region.

The injection lipolysis market growth in the U.S. is attributed to the presence of regulatory bodies that are responsible for the approval and acceptance of numerous injections, catering to the ailment of chronic disorders. For instance, in June 2021, the U.S. FDA approved Wegovy (semaglutide) injection for chronic weight supervision, especially among adults with obesity and overweight with at least one weight-related condition. This can additionally be used to reduce calorie intake and increase physical activity. Therefore, the authoritative acceptance of such injection-based drugs through regulatory organizations is uplifting the market readily.

The injection lipolysis market in Canada is subjected to expansion owing to investment-based strategies undertaken by the government. According to the May 2022 Government of Canada report, there has been the provision of USD 192 million as a fund for research and countermeasures to develop different vaccines since the onset of COVID-19. Besides, the government also provided an investment of USD 415 million to Sanofi Pasteur Limited to ensure the development of an end-to-end influenza vaccine manufacturing facility, thus a prolific opportunity for the market to expand in the country.

APAC Market Statistics

The Asia Pacific region is poised to be the fastest-growing region in the injection lipolysis market by the end of the forecast period. The growth is fueled by the acceptability and increased medical practice pertaining to this treatment in the region. Additionally, the procedure is considered an effective option for body contouring and has achieved traction owing to its capability to target localized fat deposits. Moreover, the presence of clinics and the need to maintain appropriate facial features are other factors responsible for driving the market growth in the region.

The injection lipolysis market in India is significantly growing since it is considered a standard and a non-surgical substitute to liposuction for body contouring and fat decrease in precise body areas. Additionally, the presence of dedicated hospitals and clinics in the country is also a factor driving the market development. For instance, Pristyn Care, which is located in Delhi, specializes in tailoring advanced treatments that include the utilization of Kybella injection. This injection, as stated in their 2025 report, efficiently diminishes under-chin fat by breaking down fat cells with deoxycholic acid, thus amplifying the market in the country.

The injection lipolysis market in China is gaining more exposure owing to the aspect of facial fat distribution among both the men and women populations. As per the October 2020 NLM article, patients with low face height with an approximate ethnic ideal rate of 54%, constitute exclusive facial attractiveness. The faces of people from the country are characterized by a retruded forehead, chin, and low nasal bridge, with certain features believed to bring good fortune. Therefore, based on these aspects, the market is projected to expand in the country in the upcoming years.